Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Brought to you by

NextWave Pharma completes $45mm Series C round

Jan 2011

Executive Summary

CNS- and cardiology-focused spec pharma NextWave Pharmaceuticals Inc. completed a $45mm Series C round. New investors Panorama Capital and Bay City Capital co-led the financing, which also included Kearny Venture Partners as well as returning backers Aisling Capital, Fidelity Biosciences, Sofinnova Ventures, and Vivo Ventures. Aquilo Partners was the placement agent. Panorama Capital and Bay City Capital are contributing members to NextWave's board.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By